1.
Pediatr Infect Dis J
; 40(6): e234-e235, 2021 06 01.
Article
in English
| MEDLINE
| ID: mdl-33902077
ABSTRACT
We describe the successful treatment of a 10-month-old female with respiratory distress secondary to Coronavirus disease 2019 (COVID-19) with the nebulized investigational drug, DAS181. Therapy was well tolerated, and the patient had minimal side effects. The patient's respiratory distress and positive viral polymerase chain reaction rapidly resolved after initiation of therapy.